2, Apr/Jun 2017
ARP, nº, Apr/Jun 2017
2017
Editorial
Acta Reumatológica Portuguesa: perspectives in 2017
Page numbers: 110-111
Clinical Practice
Portuguese recommendations for the use of biological therapies in patients with rheumatoid arthritis – 2016 update
Page numbers: 112-126
Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update
Page numbers: 127-140
Original articles
Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt)
Page numbers: 141-149
Risk factors for late deep infection after total hip arthroplasty in patients with rheumatoid arthritis
Page numbers: 150-154
Polymorphism rs2275913 of Interleukin-17A is related to more intensive therapy with disease-modifying anti rheumatic drugs in Mexican patients with Rheumatoid Arthritis
Page numbers: 155-161
CD13/aminopeptidase N mRNA expression and enzyme activity in Systemic Lupus Erythematosus
Page numbers: 162-167
Translation, adaptation and psychometric evaluation of the instrument Activity Record (ACTRE)
Page numbers: 168-175
Axial involvement according to ASAS criteria in an observational psoriatic arthritis cohort
Page numbers: 176-182
The relationship between serum YKL-40 levels and arterial stiffness in patients with ankylosing spondylitis
Page numbers: 183-190
Clinical Cases
Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy?
Page numbers: 191-195
Letters to the Editor
UVA1 for diffuse cutaneous systemic sclerosis in a Fitzpatrick skin type VI patient: outcomes in the modified Rodnan skin score
Page numbers: 196-197